001     186448
005     20210129214908.0
037 _ _ |a FZJ-2015-00522
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-Juel1)131773
|a Geisler, Stefanie
|b 0
|e Corresponding Author
|u fzj
245 _ _ |a Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET
260 _ _ |a Sharjah
|b Bentham Science Publ.
|c 2014
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1421654904_11842
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Proline and hydroxyproline represent major constituents of mammalian structural proteins, especially of collagen. An efficient radiosynthesis of the (18)F-labeled proline derivatives cis-/trans-4-[(18)F]fluoro-L-proline was developed two decades ago with the aim to investigate various diseases with altered collagen synthesis using Positron-Emission- Tomography (PET). A number of studies have explored cis-4-[(18)F]fluoro-L-proline uptake in various pathologies associated with increased collagen formation and in neoplastic lesions, but so far the results have not been very promising. Trans-4-[(18)F]fluoro-L-proline has not yet been investigated in detail, however the compound exhibits considerable differences in metabolic behavior and biodistribution compared with its cis-enantiomer. In recent years, the D-isomers of cis- /trans-4-[(18)F]fluoro-proline have been considered as PET tracers as well, and it was observed that both exhibit a preferred uptake into the brain compared with their L-isomers. Surprisingly, a high uptake of cis-4-[(18)F]fluoro-D-proline was found in brain areas exhibiting secondary neurodegeneration as well as in areas of radionecrosis after treatment of brain tumors. In this article, the present knowledge on the biological and physiological properties of cis-/trans-4-[(18)F]fluoro-D/L-proline and the results in various pathologies are reviewed, including some previously unpublished results from our laboratory.
536 _ _ |a 333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)
|0 G:(DE-HGF)POF2-333
|c POF2-333
|f POF II
|x 0
536 _ _ |a 89572 - (Dys-)function and Plasticity (POF2-89572)
|0 G:(DE-HGF)POF2-89572
|c POF2-89572
|x 1
|f POF II T
700 1 _ |0 P:(DE-Juel1)131818
|a Ermert, Johannes
|b 1
|u fzj
700 1 _ |0 P:(DE-Juel1)131627
|a Stoffels, Gabriele
|b 2
|u fzj
700 1 _ |0 P:(DE-Juel1)144347
|a Willuweit, Antje
|b 3
|u fzj
700 1 _ |0 P:(DE-Juel1)143792
|a Galldiks, Norbert
|b 4
|u fzj
700 1 _ |0 P:(DE-Juel1)141877
|a Filss, Christian
|b 5
|u fzj
700 1 _ |0 P:(DE-Juel1)131794
|a Shah, N. J.
|b 6
|u fzj
700 1 _ |0 P:(DE-Juel1)131816
|a Coenen, Heinrich Hubert
|b 7
|u fzj
700 1 _ |0 P:(DE-Juel1)131777
|a Langen, Karl-Josef
|b 8
|u fzj
773 _ _ |0 PERI:(DE-600)2433114-4
|p 123-132
|t Current radiopharmaceuticals
|v 7
|x 1874-4710
|y 2014
909 C O |o oai:juser.fz-juelich.de:186448
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131773
|a Forschungszentrum Jülich GmbH
|b 0
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131818
|a Forschungszentrum Jülich GmbH
|b 1
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131627
|a Forschungszentrum Jülich GmbH
|b 2
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)144347
|a Forschungszentrum Jülich GmbH
|b 3
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)143792
|a Forschungszentrum Jülich GmbH
|b 4
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)141877
|a Forschungszentrum Jülich GmbH
|b 5
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131794
|a Forschungszentrum Jülich GmbH
|b 6
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131816
|a Forschungszentrum Jülich GmbH
|b 7
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131777
|a Forschungszentrum Jülich GmbH
|b 8
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-572
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v (Dys-)function and Plasticity
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Funktion und Dysfunktion des Nervensystems
|1 G:(DE-HGF)POF2-330
|0 G:(DE-HGF)POF2-333
|2 G:(DE-HGF)POF2-300
|v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
913 1 _ |a DE-HGF
|0 G:(DE-HGF)POF2-89572
|v (Dys-)function and Plasticity
|x 1
|4 G:(DE-HGF)POF
|1 G:(DE-HGF)POF3-890
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-800
|b Programmungebundene Forschung
|l ohne Programm
914 1 _ |y 2014
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 1
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)INM-4-20090406
981 _ _ |a I:(DE-Juel1)INM-5-20090406


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21